Business / Finance

RSS

UK bioindustry raises $250m in financing during second quarter 2011

The UK bioindustry has raised over $250m in financing during the second quarter of 2011, the largest amount raised in any quarter for one year, and the second largest amount raised in any of the last 20 quarters.

30 Jul 2011

Standard Register reports net loss of $0.9 million for second quarter 2011

Standard Register today announced its financial results for the second quarter.

30 Jul 2011

EGT transfers clinical grade lentiviral vector to MSKCC

Errant Gene Therapeutics, LLC, a pioneering boutique drug development firm specializing in Rare Diseases, announced the transfer of its clinical grade lentiviral vector, TNS 9.55.3, to Memorial Sloan Kettering Cancer Center.

29 Jul 2011

Anthera reports increase in second quarter total operating expenses to $22.7 million

Anthera Pharmaceuticals, Inc., today announced financial results and business highlights for the quarter ended June 30, 2011.

29 Jul 2011

Amgen reports 8% increase in second quarter total product sales to $3,893 million

Amgen reported total revenue increased 4 percent during the second quarter of 2011 to $3,959 million versus $3,804 million in the second quarter of 2010. Total product sales increased 8 percent in the second quarter of 2011 to $3,893 million versus $3,613 million in the second quarter of 2010. The increase in total revenue in the second quarter of 2011 included a decline in other revenue due to certain milestone payments earned in the second quarter of 2010.

29 Jul 2011

Merck reports worldwide sales of $12.2 billion for second quarter 2011

Merck, known as MSD outside the United States and Canada, today announced financial results for the second quarter of 2011.

29 Jul 2011

Span-America announces quarterly dividend of $0.11 per share

Span-America Medical Systems, Inc. announced today that the Board of Directors declared a regular quarterly dividend of $0.11 per share.

29 Jul 2011

LifePoint Hospitals second quarter revenues increase 11.0% to $877.6 million

LifePoint Hospitals, Inc. today announced results for the second quarter and six months ended June 30, 2011.

29 Jul 2011

HMS second quarter revenue increases 26% to $89.3 million

HMS today announced its financial results for the second quarter of 2011.

29 Jul 2011

Amerigroup second quarter total revenues increase 6.3% to $1.53 billion

Amerigroup Corporation today announced that net income for the second quarter of 2011 was $44.3 million, or $0.83 per diluted share, versus net income of $67.2 million, or $1.31 per diluted share, for the second quarter of 2010 and compared to $70.5 million, or $1.37 per diluted share, for the first quarter of 2011.

29 Jul 2011

Aon second quarter total revenue increases 48% to $2.8 billion

Aon Corporation today reported results for the second quarter ended June 30, 2011.

29 Jul 2011

Magellan reports second quarter net revenue of $698.3 million

Magellan Health Services Inc. today reported financial results for the second quarter of 2011, as summarized below. For the quarter ended June 30, 2011, the company reported net revenue of $698.3 million, segment profit of $75.9 million, and net income of $34.2 million or $1.07 per diluted common share.

29 Jul 2011

Coventry Health Care second quarter operating revenues increase 6% to $3.0 billion

Coventry Health Care, Inc. today reported consolidated operating results for the quarter ended June 30, 2011.

29 Jul 2011

Roka Bioscience raises $20M in Series C equity financing

Roka Bioscience, Inc. announced today that it recently completed a Series C round of equity financing, raising $20 million in new capital.

29 Jul 2011

AccuVein announces $22.5M Series B financing

AccuVein Inc., a global leader in medical imaging technology and the creator of the AV300, the world's first hand-held, non-contact vein illumination device, announced today that it has secured $22.5 million in a Series B financing.

29 Jul 2011

Curis second quarter net loss increases to $4.9 million

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today reported its financial results for the second quarter ended June 30, 2011.

28 Jul 2011

Celgene reports second quarter total revenue of $1.18 billion

Celgene Corporation announced non-GAAP net income of $417 million, or non-GAAP diluted earnings per share of $0.89, for the quarter ended June 30, 2011. Non-GAAP net income for the second quarter of 2010 was $323 million, or non-GAAP diluted earnings per share of $0.69.

28 Jul 2011

NeuroMetrix second quarter total revenues decrease to $2.6 million

NeuroMetrix, Inc., a science-based health care company improving patient care through neurotechnology, today reported business and financial highlights for the quarter and six months ended June 30, 2011.

28 Jul 2011

Solazyme launches anti-aging skincare line, Algenist at Space NK stores

Solazyme, Inc., a renewable oil and bioproducts company, has signed a distribution agreement with the United Kingdom's most innovative beauty retailer, Space NK, to expand the sales network of the company's luxury skincare line, Algenist, to include all 60 Space NK stores throughout the country.

28 Jul 2011